Skip to main content

Table 1 Demography and laboratory parameters

From: Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients

Age, years

71 (61–77)

Female/male, n

11/33

Dialysis vintage, months

36 (20–72)

Body mass index, kg/m2

25.0 (23.0–29.5)

Diabetes mellitus, n

23

Cardiovascular disease, n

30

Primary kidney disease, n

Diabetes mellitus

12

Chronic glomerulonephritis

5

Nephrosclerosis

7

Polycystic kidney disease

4

Vasculitis

2

Other or unknown disease

14

Medications, n

Beta-blockers

25

ACEi/ARBs

9

Statins

15

  1. Data presented as number of patients (n), or as median and interquartile range (IQR). Abbreviations: ACEi angiotensin converting enzyme inhibitor, ARBs angiotensin receptor blockers